S. Penugonda

发表

Human APOBEC3 Induced Mutation of Human Immunodeficiency Virus Type-1 Contributes to Adaptation and Evolution in Natural Infection

M. Malim, D. Richman, Eun-Young Kim, 2014, PLoS pathogens.

Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1.

I. Adewole, S. Penugonda, B. Taiwo, 2010, Current HIV research.

BK Virus Replication and Nephropathy After Alemtuzumab‐Induced Kidney Transplantation

J. Friedewald, S. Penugonda, M. Ison, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Keratinization of the adult male foreskin and implications for male circumcision

T. Hope, S. Penugonda, M. McRaven, 2010, AIDS.

Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia

J. Goedert, J. Fellay, C. Winkler, 2016, PLoS genetics.

Diagnostic yields in solid organ transplant recipients admitted with diarrhea.

S. Penugonda, M. Ison, V. Stosor, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy

S. Penugonda, Steven Wolinsky, Alexander G. Holman, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Monitoring seasonal influenza A evolution: rapid 2009 pandemic H1N1 surveillance with an reverse transcription-polymerase chain reaction/electro-spray ionization mass spectrometry assay.

R. Sampath, D. Metzgar, S. Penugonda, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Optimal strategies for the diagnosis of community‐onset diarrhea in solid organ transplant recipients: Less is more

S. Penugonda, M. Angarone, I. Echenique, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials

S. Penugonda, G. Cicconetti, Yanhong Zhou, 2022, Pharmaceutical statistics.

Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.

I. Adewole, S. Penugonda, B. Taiwo, 2008, Annals of hepatology.

Persistent HIV-1 replication maintains the tissue reservoir during therapy

Trevor Bedford, Sergei L. Kosakovsky Pond, Angela R. McLean, 2015, Nature.

Safety and efficacy of chronic suppressive azole therapy for endemic fungal infections in solid organ transplant recipients

S. Penugonda, M. Angarone, I. Echenique, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections: Study of a 2-State Monoclonal Outbreak

S. Penugonda, J. Quinn, R. Weinstein, 2010, Infection Control & Hospital Epidemiology.

Ganciclovir‐resistant cytomegalovirus infection in solid organ transplant recipients: a single‐center retrospective cohort study

S. Penugonda, M. Ison, V. Stosor, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co‐infected Nigerians

S. Penugonda, R. Murphy, C. Hawkins, 2017, Tropical medicine & international health : TM & IH.

R. Detels, S. Penugonda, Zuo-Feng Zhang, 2016, Cancer epidemiology.

Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients

S. Penugonda, B. Taiwo, C. Achenbach, 2017, Journal of acquired immune deficiency syndromes.

Lorenzo-Redondo et al. reply

Trevor Bedford, Sergei L. Kosakovsky Pond, Angela R. McLean, 2017, Nature.

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

J. Margolick, S. Penugonda, O. Martínez-Maza, 2015, AIDS.

A Phase 1b, Open-Label Study of Eftozanermin Alfa in Combination with Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

S. Penugonda, P. Richardson, M. Motwani, 2020 .

Temporal Stability of Serum Concentrations of Cytokines and Soluble Receptors Measured Across Two Years in Low-Risk HIV-Seronegative Men

R. Detels, S. Penugonda, O. Martínez-Maza, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Improving Syphilis Screening in Deceased Organ Donors

S. Penugonda, M. Ison, D. Ladner, 2015, Transplantation.

The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.

S. Penugonda, Steven Wolinsky, Man Li, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Identification of Siglec-1 null individuals infected with HIV-1

M. Carrington, J. Fellay, A. Telenti, 2016, Nature Communications.

A first-in-human study of mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose escalation results.

S. Penugonda, A. Tolcher, P. LoRusso, 2021 .

No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death

J. Becker, L. Kingsley, S. Penugonda, 2015, Journal of NeuroVirology.

Patient-selected treatment partners did not protect against drug resistance during first-line NNRTI-based HAART in a randomized trial.

S. Penugonda, B. Taiwo, R. Murphy, 2010, Journal of acquired immune deficiency syndromes.

Connection Domain Mutations During Antiretroviral Treatment Failure in Mali: Frequencies and Impact on Reverse Transcriptase Inhibitor Activity

V. Calvez, S. Penugonda, B. Taiwo, 2012, Journal of acquired immune deficiency syndromes.